3R4-27742-68067
3 vaccinations
2 coded responses
13 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 402 / KY
- Registered
- 2021-11-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
Q3D-18098-58052
Child or adolescent in my care · Female · 2022-06-27
CVD-17941-96029
Child or adolescent in my care · Female · 2022-06-27
Timeline
-
2021-03-05
Dose 1 — Pfizer-BioNTech
-
2021-04-15
Dose 2 — Pfizer-BioNTech
-
2021-11-04
Registered in v-safe
-
2021-11-04
Dose 3 — Pfizer-BioNTech
- 2021-11-05
-
2021-11-05
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2021-11-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-07
- 2021-11-08
- 2021-11-13
- 2021-11-18
- 2021-11-25
- 2021-12-02
- 2021-12-09
- 2021-12-16
-
2022-02-03
Survey response — 3 months, dose 3MedDRA: Cough, Nasopharyngitis, Sinusitis — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cold with a cough and sinus infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-02-03
Report sent to call center — 3 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-04
-
2022-05-05
Survey response — 6 months, dose 3MedDRA: Nasopharyngitis, Sinusitis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cold/sinus infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-05-05
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-05 | Pfizer-BioNTech | No |
| 2 | 2021-04-15 | Pfizer-BioNTech | No |
| 3 | 2021-11-04 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-03 | Unsuccessful | |
| 2022-05-05 | Unsuccessful |
Free text
Release 11 — 3 months, dose 3
Symptoms: Cold with a cough and sinus infection
Release 11 — 6 months, dose 3
Symptoms: Cold/sinus infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release